Given rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya has recently approved registering Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults.
Covovax will be available on the portal in the coming days, priced at nearly ₹225/dose, excluding GST.
This action succeeded a request by Prakash Kumar Singh, Director, Serum Institute of India (SII), to the Union health ministry on 27/03/2023, which stated that Covovax is a world-class vaccine approved by the DCGI, WHO, and USFDA and proposed its inclusion as a heterologous booster vaccine for adults on the CoWIN portal.
Subscribe To Our Newsletter
Filter out the noise and nurture your inbox with health and wellness advice that's inclusive and rooted in medical expertise.
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please update your details
Please login to comment on this article